Triple

T5873218
Position Surface form Disambiguated ID Type / Status
Subject HMA Multi-Annual Work Plan E130566 entity
Predicate appliesTo P1129 FINISHED
Object European Heads of Medicines Agencies network E23506 NE FINISHED

How this triple was built (2 steps)

Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.

NER Named-entity recognition gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: European Heads of Medicines Agencies network | Statement: [HMA Multi-Annual Work Plan, appliesTo, European Heads of Medicines Agencies network]
NED1 Entity disambiguation (via context triple) gpt-5-mini-2025-08-07 
Target entity: European Heads of Medicines Agencies network
Context triple: [HMA Multi-Annual Work Plan, appliesTo, European Heads of Medicines Agencies network]
  • A. European medicines regulatory authorities
    European medicines regulatory authorities are national and regional agencies in Europe responsible for evaluating, authorizing, and monitoring the safety, quality, and efficacy of medicinal products.
  • B. European Medicines Agency
    The European Medicines Agency is the European Union’s regulatory authority responsible for the scientific evaluation, supervision, and safety monitoring of medicines for human and veterinary use.
  • C. European Directorate for the Quality of Medicines & HealthCare
    The European Directorate for the Quality of Medicines & HealthCare is a Council of Europe body responsible for developing quality standards and guidance to ensure the safety and efficacy of medicines and improve healthcare across member states.
  • D. Committee for Medicinal Products for Human Use
    The Committee for Medicinal Products for Human Use is the European Medicines Agency’s expert body responsible for evaluating and providing scientific opinions on the safety, quality, and efficacy of medicines for human use in the European Union.
  • E. Heads of Medicines Agencies chosen
    Heads of Medicines Agencies is a European network of national medicines regulatory authorities that collaborates to coordinate and harmonize the regulation of medicinal products across EU and EEA member states.
  • F. None of above.
  • G. Unsure - the case is ambiguous/there is not enough information to decide.

Provenance (3 batches)

The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.

Step Stage Batch ID Status When
creating Elicitation batch_69c0085047dc8190af24e311edad3c07 completed March 22, 2026, 3:18 p.m.
NER Named-entity recognition batch_69c035f99b788190b5b06d83b9499bfa completed March 22, 2026, 6:33 p.m.
NED1 Entity disambiguation (via context triple) batch_69c107fd138c819092096f473be3e4cf completed March 23, 2026, 9:29 a.m.
Created at: March 22, 2026, 3:56 p.m.